Maximising Drug Discovery Research- Interview with Attana CEO, Teodor Aastrup
"Drug discovery scientists should focus on the biological relevance of their candidate molecules as soon as possible in their research, to ensure a high probability of success in later stages”, says Teodor Aastrup, Chief Executive Officer and Founder of Attana AB. To maximise productivity, there is a need to understand reactions and interactions in the human body before research has advanced too much."
Click here to read the entire interview or access the pdf attached below.
- Medical research
- drug discovery
- marcus evans
- discovery summit 2011
- attana cell 200